The Irish Times – Thursday, February 10, 2011
The vaccination programme began in second-level schools last May and about 90,000 doses of the vaccine have now been administered. The vaccine is given in three doses and at this stage the majority of girls have received their second dose.
The IMB said yesterday, after releasing its latest annual report, that it had received a total of 314 reports of adverse events associated with use of the Gardasil vaccine up to the end of January 2011.
It said the majority of the reports have been “non-serious and consistent with the expected pattern of adverse effects for the vaccine, as described in the product information and include cases of malaise, headache, dizziness, syncope [fainting], fatigue, skin and injection site reactions and gastrointestinal symptoms”.